Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials

By Blum Joanne   Kohles Joseph   McKenna Edward   Scotto Nana   Hu Sylvia   Odom Dawn   Kaye James   Glück Stefan  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 431-439

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer

By Shitara Kohei   Matsuo Keitaro   Muro Kei   Doi Toshihiko   Ohtsu Atsushi  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 362-370

Springer Publishing Company

Access to resources Recommend Favorite

End points in lung cancer clinical trials: are we ready to step away from overall survival?

By Mandrekar Sumithra J  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 467-470

Future Medicine

Access to resources Recommend Favorite

Clinical Trials in Cancer: Principles and Practice

By Perrone F.  

Lancet Oncology, Vol. 4, Iss. 12, 2003-12 ,pp. : 775-775

Elsevier

Access to resources Recommend Favorite

Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments

By Morita Satoshi   Kaptein Adrian A.   Tsuburaya Akira   Kodera Yasuhiro   Matsui Takanori   Sakamoto Junichi  

Gastric Cancer, Vol. 9, Iss. 4, 2006-11 ,pp. : 254-261

Springer Publishing Company

Access to resources Recommend Favorite